I am a medical doctor, aspiring surgeon and ph.d.-student. My primary area of interest lies in surgical pathophysiology with a focus on the inflammatory response, immune response and tumor microenvironment, especially in colorectal cancer. Further, I have a special interest in identifying and optimization of the ‘high risk’ surgical patient. I believe that the biggest improvements in the surgical field in the near future, lies in understanding and improving the physiology and immune response prior to surgery.
I have been a MD since 2014, and when I did my clinical rotations, I studied the risk of developing cancer in inflammatory bowel diseases and the inflammation-dysplasia-carcinoma mechanism. This interest into the immune systems negative effect on cancer progression and outcomes, lead me to the realization that we need efforts into preoperative anti-inflammatory strategies and improving the positive aspects of the immune system. All three of my interest have merged in the current randomized controlled study PREHAB-DK (Dansk: Klar til Kirurgi), in which we try to improve physiological fitness, decrease chronic inflammation, and improving immunological microenviroment, through multimodal ‘prehabilitation’ prior to surgery in high risk colorectal cancer patients.
Besides my research obligations, I perform part time clinic duties as a junior Surgeon at the Department of Surgery, Slagelse Hospital. I also work as a medical illustrator on freelance basis.
Ph.d. – student Dec. 2017 – University of Copenhagen, Center for Surgical Science and Department of Surgery, Slagelse Hospital.
Clinical doctor: 2014 – 2016 – Finished first year of residency in Surgery.
MD – 2014 – University of Copenhagen
BaMSC – 2010 –University of Southern Denmark
The focus of my current research lies in understanding the impact of preoperative interventions effect on the human physiology and immunology, especially in colonic or rectal cancer. Thus, the field of interest and methodology ranges wide: from epidemiology, pathophysiology, to case control- and clinical randomized studies. We are using a wide range of methods in the studies including physical assessments with Cardio Pulmonary Exercise Testing, Inflammatory markers, transcription analysis and other omics.
- Friis-Andersen M, Bojesen RD, Gögenur I; Referral to postoperative oncological treatment after surgery in stage III in elderly colorectal cancer patients. Under Review
- Bojesen RD, Ravn JE, Munk-Madsen P, Fitzgerald P, Kehlet H, Gögenur I; Postoperative episodic hypoxemia and its influence on recovery in 115 colorectal cancer patients within an optimal ERAS (Enhanced Recovery After Surgery) protocol. Under review.
- Bojesen RD, Dalton S, Degett TH, Gögenur I; WHO performance status and the increased risk of complications and death in colorectal cancer – nationwide population based study. Under review
- Van Rooijen S, Carli F, Dalton S, Thomas G, Bojesen RD, et al.; Multimodal prehabilitation versus regular care in colorectal cancer patients to improve functional capacity and reduce postoperative complications: The first international randomized controlled trial for multimodal prehabilitation. Accepted BMC Cancer
- Bojesen RD, Riis LB, Høgdall E, Nielsen OH, Jess T; Inflammatory Bowel Disease and Small Bowel Cancer: Risk, clinical characteristics and histopathology. Clin Gastroenterol Hepatol. 2017 Jul 8. PMID: 28694132
- Bojesen RD, Andersson M, Riis LB, Nielsen OH, Jess T; Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study. J gastroenterol. 2016 PMID: 26847562
- Nielsen OH, Riis LB, Danese S, Bojesen RD, Soendergaard C: Proximal collagenous gastroenteritides: clinical management. A systematic review. Ann med 2014 PMID: 24716737
Credits – Acknowlegdements:
2 poster and 2 Oral presentations at international conferences
“Poster of Distinction” at European Crohn´s and Colitis Organisation (ECCO) Vienna 2013
LAST UPDATE: NOV 2018